Replies to post #299 on NeoGenomics Inc (NEO)

[conix]

NeoGenomics (NASDAQ:NEO) was downgraded by analysts at Stephens from an "overweight" rating to an "equal weight" rating. They now have a $16.00 price target on the stock, down previously from $34.00.This represents a 37.5% upside from the current price of $11.64.